Qinqin Xu
Overview
Explore the profile of Qinqin Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
666
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang Z, Karaboue A, Zeng L, Lecoeuvre A, Zhang L, Li X, et al.
EBioMedicine
. 2025 Feb;
113:105607.
PMID: 39983330
Background: Circadian rhythms regulate immune cell activity, influencing responses to vaccines, and immune checkpoint inhibitors (ICIs). Early time-of-day administration (ToDA) of singe-agent ICIs has been associated with improved overall survival...
2.
Song L, Xu Q, Zhong T, Guo W, Lin S, Jiang W, et al.
Chin Med J (Engl)
. 2025 Feb;
138(4):478-480.
PMID: 39967297
No abstract available.
3.
Gan J, Zhang L, Xu Q, Guo Y, Xie H
Int J Biol Macromol
. 2025 Feb;
:140798.
PMID: 39924021
The dissolution and homogeneous processing of lignocellulosic biomass presents a significant challenge for advanced biorefineries. In this work, we firstly investigated the dissolution behavior of corn stover-based lignocellulose in 1,8-diazabicyclo...
4.
Zeng L, Yan H, Jiang W, Qin H, Dai J, Zhang Y, et al.
Med
. 2025 Feb;
:100574.
PMID: 39892382
Background: Perioperative treatment with toripalimab combined with chemotherapy was efficacious and safe in resectable stage II-IIIA non-small cell lung cancer (NSCLC); however, little is known about whether this treatment regimen...
5.
Liu X, Sun Y, Gao C, Sun H, Tian F, Xiao F, et al.
Transl Cancer Res
. 2025 Jan;
13(12):6956-6969.
PMID: 39816544
Background: Many cancer cells exhibit aberrant metabolic reprogramming through abnormal mitochondrial respiration. Protein tyrosine phosphatase mitochondrial 1 (PTPMT1) is a protein tyrosine phosphatase localized to the mitochondria and linked to...
6.
Song L, Yan H, Xu Q, Zhou C, Liang J, Lin S, et al.
JTO Clin Res Rep
. 2024 Nov;
5(12):100729.
PMID: 39502496
Introduction: Despite receiving alectinib therapy, patients with ALK-positive NSCLC remain at risk of central nervous system (CNS) progression. Our retrospective study aimed to identify baseline clinical and molecular factors associated...
7.
Qin H, Huang Z, Yan H, Song L, Zeng L, Xu Q, et al.
iScience
. 2024 Oct;
27(10):110910.
PMID: 39351193
This retrospective study demonstrated that patients with advanced non-small cell lung cancer who experienced any-grade or grade 1-2 immune-related adverse events (irAEs) with immune checkpoint inhibitor plus chemotherapy (ICI+Chemo) as...
8.
Li S, Xu M, Chen K, Wu Q, Li Y, Xie C, et al.
J Colloid Interface Sci
. 2024 Sep;
678(Pt C):934-947.
PMID: 39326165
Despite the high safety and low cost associated with aqueous Zn-ion batteries (ZIBs), uncontrolled Zn dendrite growth and parasitic reactions induced by water significantly diminish their stability. Herein, a new...
9.
Chen H, Zhou H, Zhang X, Ding Y, Zhang X, Xu Q, et al.
Chem Commun (Camb)
. 2024 Aug;
60(71):9618-9621.
PMID: 39150158
The synthesis of HO-activatable small molecules in the second near-infrared (NIR-II) window remains challenging. We present the NIR-II probe Z-1065 for real-time detection of HO. Z-1065 demonstrates high sensitivity and...
10.
Qin H, Yan H, Chen Y, Xu Q, Huang Z, Jiang W, et al.
BMC Cancer
. 2024 Aug;
24(1):952.
PMID: 39097705
Background: Limited data exists on the efficacy of immune checkpoint inhibitor (ICI) combinations in non-small-cell lung cancer (NSCLC) with uncommon driver alterations in genes such as ERBB2, BRAF, RET, and...